NEO
Neogenomics Inc.

2,863
Mkt Cap
$1.02B
Volume
1.44M
52W High
$13.74
52W Low
$4.72
PE Ratio
-9.34
NEO Fundamentals
Price
$7.88
Prev Close
$7.98
Open
$8.05
50D MA
$11.19
Beta
1.38
Avg. Volume
1.97M
EPS (Annual)
-$0.8433
P/B
1.22
Rev/Employee
$290,932.80
$1,756.31
Loading...
Loading...
News
all
press releases
Silverback Asset Management LLC Invests $1.55 Million in NeoGenomics, Inc. $NEO
Silverback Asset Management LLC bought a new position in shares of NeoGenomics, Inc. (NASDAQ:NEO - Free Report) in the third quarter, according to the company in its most recent filing with the SEC...
MarketBeat·1d ago
News Placeholder
More News
News Placeholder
NeoGenomics (NASDAQ:NEO) Stock Price Down 7.9% - Should You Sell?
NeoGenomics (NASDAQ:NEO) Stock Price Down 7.9% - Should You Sell...
MarketBeat·3d ago
News Placeholder
Greenhouse Funds LLLP Acquires 789,510 Shares of NeoGenomics, Inc. $NEO
Greenhouse Funds LLLP increased its stake in NeoGenomics, Inc. (NASDAQ:NEO - Free Report) by 10.6% during the 3rd quarter, according to the company in its most recent disclosure with the Securities...
MarketBeat·3d ago
News Placeholder
GW&K Investment Management LLC Cuts Stock Position in NeoGenomics, Inc. $NEO
GW&K Investment Management LLC reduced its position in NeoGenomics, Inc. (NASDAQ:NEO - Free Report) by 15.8% during the 3rd quarter, according to its most recent Form 13F filing with the Securities...
MarketBeat·8d ago
News Placeholder
Royce & Associates LP Sells 860,000 Shares of NeoGenomics, Inc. $NEO
Royce & Associates LP lessened its stake in NeoGenomics, Inc. (NASDAQ:NEO - Free Report) by 86.6% during the third quarter, according to its most recent filing with the Securities and Exchange...
MarketBeat·8d ago
News Placeholder
Vanguard Group Inc. Has $107.34 Million Stock Position in NeoGenomics, Inc. $NEO
Vanguard Group Inc. lessened its holdings in shares of NeoGenomics, Inc. (NASDAQ:NEO - Free Report) by 1.6% in the third quarter, according to its most recent 13F filing with the Securities and...
MarketBeat·10d ago
News Placeholder
NeoGenomics, Inc. $NEO Shares Sold by Segall Bryant & Hamill LLC
Segall Bryant & Hamill LLC trimmed its holdings in NeoGenomics, Inc. (NASDAQ:NEO - Free Report) by 23.1% during the third quarter, according to the company in its most recent filing with the...
MarketBeat·11d ago
News Placeholder
NeoGenomics (NASDAQ:NEO) Stock Price Crosses Below 200-Day Moving Average - Here's What Happened
NeoGenomics (NASDAQ:NEO) Shares Cross Below Two Hundred Day Moving Average - Here's What Happened...
MarketBeat·13d ago
News Placeholder
NeoGenomics Launches RaDaR ST, Expanding Molecular Residual Disease Testing Across Multiple Solid Tumor Types
NeoGenomics, Inc. (NASDAQ: NEO), a leading provider of oncology diagnostic solutions that enable precision medicine, today announced the launch of RaDaR ST, its circulating tumor DNA (ctDNA) assay...
Business Wire·18d ago
News Placeholder
NeoGenomics, Inc. (NASDAQ:NEO) Receives Consensus Rating of "Hold" from Brokerages
Shares of NeoGenomics, Inc. (NASDAQ:NEO - Get Free Report) have been assigned an average rating of "Hold" from the fourteen research firms that are currently covering the stock, MarketBeat.com...
MarketBeat·20d ago
<
1
2
...
>

Latest NEO News

View
Top Discussions

Advertisement|Remove ads.

Advertisement|Remove ads.